| DC Field | Value | Language |
|---|
| dc.contributor.author | Grebinyk, A. | - |
| dc.contributor.author | Prylutska, S. | - |
| dc.contributor.author | Grebinyk, S. | - |
| dc.contributor.author | Evstigneev, M. | - |
| dc.contributor.author | Krysiuk, I. | - |
| dc.date.accessioned | 2022-10-28T13:25:29Z | - |
| dc.date.available | 2022-10-28T13:25:29Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.citation | Antitumor efficiency of the natural alkaloid berberine complexed with C₆₀ fullerene in Lewis lung carcinoma in vitro and in vivo / A. Grebinyk [et al.] // Cancer Nanotechnology. - 2021. - Vol.12.-Art. 24. - Doi: 10.1186/s12645-021-00096-6. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/48881 | - |
| dc.description.abstract | Berberine (Ber) is a herbal alkaloid with pharmacological activity in general and a high anticancer potency in particular. However, due to its low bioavailability, the difficulty in reaching a target and choosing the right dose, there is a need to improve approaches of Ber use in anticancer therapy. In this study, Ber, noncovalently bound to a carbon nanostructure C₆₀ fullerene at various molar ratios of the components, was explored against Lewis lung carcinoma | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | C₆₀ fullerene | ru |
| dc.subject | Berberine | ru |
| dc.subject | noncovalent nanocomplex | ru |
| dc.subject | Lewis lung carcinoma | ru |
| dc.subject | cell culture | ru |
| dc.subject | tumor growth | ru |
| dc.title | Antitumor efficiency of the natural alkaloid berberine complexed with C₆₀ fullerene in Lewis lung carcinoma in vitro and in vivo | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
